Clinical Trials List
Protocol NumberR092670-PSY-3001
Not yet recruiting
2005-03-01 - 2008-10-31
Phase III
Terminated4
-
Trial Applicant
Johnson & Johnson
-
Sponsor
-
Trial scale
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Principal Investigator
??
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
60 participants
-
Global
640 participants
